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Many antigens have been found to induce the formation of several molecular 
classes of antibodies. Under most circumstances, the first antibody to be syn- 
thesized in response to antigenic stimulation is a  19S  ('yM) globulin, while 7S 
immunoglobulins  (3'G) appear somewhat later. The factors controlling the syn- 
thesis of these 2 proteins are poorly understood. The recent report of the se- 
lective suppression of "),G-antibodies in rabbits by 6-mercaptopurine (6-MP) 
suggests that the formation of each of these immunoglobulins  is controlled by 
a separate mechanism (1). Furthermore, 19S antibody synthesis in man appears 
more resistant to 6-MP treatment than 7S antibody formation (2, 3).  In the 
present paper the effect on 7M- and "~,G-antibody formation of 6-MP has been 
further investigated in the primary and secondary response of mice and rabbits. 
Materials and Methods 
Animals.--White Swiss mice of both sexes weighing 25 to 30 gm and white outbred male or 
female rabbits weighing 3.5 to 4.5 kg were used. 
Immunization.--Rat erythrocytes were obtained by cardiac puncture from Wistar albino 
rats and washed 3 times with buffered (pH 7) saline. Twenty groups of 10 mice were immunized 
with an intravenous dose of 0.25 ml of a 50 per cent suspension of rat erythrocytes (large dose). 
Sixteen groups of 10 mice were immunized with an intravenous injection of a 2.5 per cent sus- 
pension of rat erythrocytes (small dose). A second injection of the same dose of rat erythrocytes 
for the appropriate group was given either 2 or 3 weeks later in order to study the anamnestic 
response. Twelve rabbits were injected intravenously with 1 ml of a 50 per cent saline suspen- 
sion of human type A erythrocytes washed 3 times. A similar injection was given 20 days later. 
Administration of 6-MP.--Six-mercaptopurine (6-MP)  1 was brought into solution in dis- 
tilled water with the minimal amount of NaOH necessary to dissolve the drug. Eight groups of 
10 mice were treated daffy with 50 mg/kg/body weight intraperitoneally for the first 10 days 
of the immunization. Ten groups of mice were given 150 mg/kg/body weight intraperitoneaUy 
for 4 days beginning on the day of the second injection. Six rabbits received two 10-day courses 
of 6-MP (6 mg/kg) beginning on the day of each antigen injection. 
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Serological Tests.--The mice were bled from a  retroorbital  vein with a  0.2  ml calibrated 
pipette.  In order to obtain enough serum for serologic studies, the blood samples from each 
group of 10 mice were pooled and allowed to clot.  Bleedings were made at regular intervals 
after each antigen injection. 
The rabbits were bled from a  marginal ear vein before the injection of the antigen and at 
5-day intervals thereafter. 
Treatment of the Serum with 2-Mercaptoethanol (ME).--Pooled mouse serum or rabbit serum 
was diluted in an equal amount of buffered saline and incubated with ME (in a final concentra- 
tion of 0.1 M) for 2 hours at room temperature. After incubation the sera were dialyzed in the 
cold overnight against buffered saline containing 0.02 m iodoacetamide. 
Antibody Activity.--Hemaggiutination  tests were performed with a  2 per cent suspension of 
rat erythrocytes. The mouse sera were diluted with buffered saline containing 2 per cent nor- 
mal mouse serum. The rabbit sera were diluted in 0.15 M saline. The tubes were incubated in a 
water-bath at 37°C for 30 minutes. The hemaggiutination was read microscopically. 
Sucrose Density Gradient Ultracenlrifugation.--The  method described by Edelman, Kunkel, 
and Franklin was used (4).  Pooled mouse serum (0.3 ml) was layered over a  gradient formed 
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FIG.  1.  Effect of subsupressive dose of 6-MP on the prhnary response in mice. At day 0, 
the animals were  immunized intravenously with  0.25  ml of 50 per  cent  suspension of  rat 
erythrocytes. Six representative groups are shown in this figure. Each column  represents the result 
of hemagglutination obtained with pooled sera from a group of 10 mice. Two groups served as 
control and 4 groups were treated with 6-MP. Black, column: ME-sensitive antibody activity. 
Hatched column: ME-resistant antibody activity. Y.  BOREL~ M.  FAUCONNEr~  AND  P.  A.  MIESCHER  265 
from 37.5,  25, and 12.5 per cent sucrose.  Centrifugation was performed in a  Spinco model L 
ultracentrifuge with a SW 39 swinging bucket rotator at 32,000 gP~ for 16 to 18 hours. Twelve 
to 14 fractions were collected through a small perforation at the bottom of the centrifuge tube. 
After dialysis against 0.15 x~ saline,  the protein concentration of the fraction was determined 
by the Foim-Ciocalteu method (5).  In some experiments fractions were pooled to obtain a 
rapidly sedimenting fraction rich in 195 globulin and essentially free of 75 globulin molecules, 
and a fraction containing the bulk of the 7S globulin. In other experiments individual fractions 
were examined serologically.  Aliquots of each individual or pooled fraction were then diluted 
1: 2 with buffered saline and treated with ME. Hemagglutinin activity was determined in each 
non-treated and ME-treated sample. Sera from control and 6-MP-treated mice were usually 
obtained on  the same day and  examined simultaneously. In  1  sucrose gradient  the  same 
pooled serum from 6-MP-treated animals was run together with the ME-treated serum. In 
another experiment  a human macroglobulin (19S) was used as a marker. 
Chromodography on sephadex G-200.--Pooled mouse sera (0.9 to 1 ml) were applied to col- 
unms (2.0 X  90 cm) of sephadex G-200 and eiuted in the cold at a rate of 4 to 9 ml per hour 
with 0.5 x~ NaC1. Four ml fractions were collected.  Protein concentration was measured at 280 
In#. The fractions corresponding to either the 19S or 7S peak were then dialyzed overnight 
against buffered saline and concentrated by vacuum dialysis.  An aliquot of the pooled fraction 
was treated with mereaptoethanol and hemagglutinin activity was determined in the untreated 
and ME-treated pools. In two experiments the intermediate fractions between the 19S and 7S 
peak were also concentrated and treated the same way. A protein determination of the pooled 
fractions was performed and the titer of antibody activity in all fractions was expressed in 
terms of its protein concentration. 
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FIG. 2. Effect  on the anamnestic response of  6-MP given during the primary response.  Each 
animal was injected  intravenously with 0.25 ml of 50 per cent suspension of rat erythrocytes 
at day 0 and a second similar  injection  was given at day 20. The results  are represented as in 
Fig. I. Black column: ME-sensitive  antibody activity.  Hatched column: ME-resistant anti- 
body activity. 266  6-MERCAPTOPURINE  EFFECT  ON  ANTIBODIES 
RESULTS 
Effect  of 6-MP  on  the Primary Immune  Response.--Two-mercaptoethanol 
sensitive  antibody was first detected in all  12 groups of mice 3  days after an 
injection of 0.25 ml of a  50 per cent suspension of rat erythrocytes. The max- 
imum  titer  of this  antibody was reached  on  the  fifth day and  10 days after 
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FIG. 3.  Sucrose gradient ultracentrifugation  of pooled sera from control group (left panel) 
and experimental group (right panel) treated with 6-MP during the first 10 days of immuniza- 
tion. All animals were immunized at day 0, reinjected at day 20 and bled at day 43. The pro- 
tein content of the fractions is indicated in/zg of protein per ml. The hemagglutinin activity of 
each fraction is represented below the abscissa. Brackets represent weak antibody activity. 
Black column: ME-sensitive antibody activity.  Hatched column: ME-resistant  antibody ac- 
tivity. 
antigen  administration  it was no longer found in the serum.  During  the next 
14 days all  the  antibody  was  ME-resistant  (Fig.  1).  Six-mercaptopufine  ad- 
ministration  did  not prolong  the  induction period;  however,  the  4  groups of 
mice given 6-MP had lower titers of antibody initially. The appearance of ME- 
resistant  antibody was delayed by 6-MP in 2  groups of mice and diminished 
in all 4  groups throughout the experiment.  In contrast to the control groups, 
the  6-MP-treated  mice  continued  to  produce  ME-sensitive  antibody  for at 
least  24 days after  the antigenic  stimulus.  Sera of 6-MP-treated  animals  ob- 
tained  19  days after  immunization  were analyzed by sucrose  gradient  ultra- Y.  BOR.EL~ M.  I~'AUCONNET,  AND P.  A.  MIESCHER  267 
centrifugation.  At  the  same  time  sera  of control  mice bled  at  day  5,  which 
contained  only ME-sensitive  antibody  activity,  were  similarly  analyzed.  In 
both cases the ME-sensitive antibody was found only in the heavy fractions. 
The ME-resistant  antibody present in the sera of the 6-MP-treated  mice was 
found in the upper fractions. 2 
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FI6. 4.  Effect on the anamnestic response of 6-MP given during the anamuestic response, 
'qarge dose" of rat erythrocytes. Each animal was immunized at day 0 with 0.25 ml of 50 per 
cent suspension of rat erythrocytes.  At day 15 only ME-resistant  antibody activity could be 
demonstrated. After a second intravenous injection of 0.25 ml of 50 per cent suspension of rat 
erythrocytes at day 16, a considerable proportion of the antibody activity became ME-sensi- 
tive. Six-mercaptopurine administration did not influence the pattern of the antibody response. 
The results in control and 6-MP-treated mice given 0.25 ml of 2.5 per cent 
suspension of rat  erythrocytes were the same as those given the "large dose" 
(0.25 ml of 50 per cent suspension)  and will not be described in detail. 
Effect  on  the  Anamnestic  Response of  6-MP  Given during  the  Primary 
Response.--One  group of 10 control mice and 2 groups of 10 experimental mice 
were reinjected on day 20 with 0.25 ml of a 50 per cent suspension of rat eryth- 
rocytes.  The  results  are  presented  in  Fig.  2.  Two-mercaptoethanol-sensitive 
agglufinin was found in the sera of control mice only on the  1st day after the 
2 Sucrose gradient was made up with 15 x, NaC1 and distilled water. No difference was seen. 268  6-MERCAPTOPURINE  EFFECT  ON  ANTIBODIES 
booster injection; subsequently all the antibody was ME-resistant. In contrast, 
ME-sensitive antibody was present in the 6-MP-treated mice for at least 43 
days after  the  second dose of antigen.  The  agglutinin titers in all groups  of 
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FiG. 5.  Effect on the anamnestic response of 6-3alp given during the anamnestic response, 
"small dose" of rat erythrocytes. Each animal was immunized at day 0 with 0.25 ml of 2.5 per 
cent  suspension  of  rat  erythrocytes.  At  day  20  and  21  all  animals  exhibited  ME- 
resistant hemagglutinin activity. Mter a second injection with the same dose, only 1 of 5 con- 
trol groups exhibited a small proportion of ME-sensitive antibody activity (group 2). In con- 
trast, aU 5 groups of animals which received 6-MP developed a large proportion of ME-sensi- 
tive antibody activity. Note the drop of ME-resistant hemagglutinin activity in the 6-MP- 
treated mice The 5 groups of control and the 5 groups of 6-MP-treated mice are numbered 
consistently throughout the experiment with numbers  1 to 5.  Black column:  ME-sensitive 
antibody activity. Hatched column: ME-resistant antibody activity. 
mice were similar. A  sucrose density gradient analysis done  23 days after the 
booster injection is shown in Fig. 3. 
Effect on the Anamnestic Response of 6-MP Given  during the Anamnestic Re- 
sponse.--Eight  groups of 10 mice immunized with a  large dose of rat erythro- 
cytes and reinjected on either day 14 or 20 with the same dose of antigen pro- 
duced ME-sensitive in addition to ME-resistant antibody for only a  few days 
after the second antigen injection. Six-mercaptopurine treatment (150 mg/kg) 
for 4  days starting on the day of the second antigen injection did not alter the 
immune response. Four representative groups are shown on Fig. 4. Y. BOREL~  M. FAUCONNET,  AND  P. A. MIESCHE]~  269 
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Five  groups d  10 mice  injected with a  small  dose  of foreign red cells and 
reinjected on day 20 with the same  dose of antigen produced an anamnestic 
response consisting almost exclusively of ME-resistant antibody activity. The 
anamnesfic response in 5 groups of mice treated with 6-MP as mentioned above 
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FIG. 7.  Chromatography on sephadex G-200. The  same pooled serum of experimental 
group 5, which was submitted to sucrose gradient ultracentrifugation (see Fig. 6) was sub- 
jected to chromatography  on sephadex G-200. The following 3 pooled fractions were adjusted 
with buffered saline to a protein concentration of 0.4 mg of protein/ml: fractions 12 to 14, 17 to 
19, 23 to 25.  These 3  pooled fractions were assayed for hemaglutinin activity.  It should be 
noted  that a  control serum which exhibited only ME-resistant  hemagglutinin  activity also 
showed a ME-resistant titer of 1:2 in the fractions 12 to 14 containing the bulk of "y M-globu- 
]in. Black column: ME-sensitive antibody activity. Hatched column: ME-resistant antibody 
activity. 
was qualitatively different. A considerable proportion of antibody activity was 
ME-sensitive  1 day after the booster injection. Three days later group 3  and 
group 4  (see Fig.  5) had only ME-sensitive  agglutinins. Mter discontinuation 
of 6-MP treatment the ME-sensitive antibody in the 3 other groups increased. 
A  large proportion of the antibody activity remained  ME-sensitive  in all ex- 
perimental  groups for  16  days  after  the  second antigen injection.  Untreated 
and ME-treated  serum of the group  1 of 6-MP-treated  mice at day 28 were 
analyzed  by  sucrose  gradient  ultracentrifugation.  The untreated  serum  con- 
tained  antibody  activity  in  the  light and  heavy fractions, whereas  the ME- Y. BOREL~ ~r. FAUCONNET~  AND  P. A. MIESCHER  271 
treated  serum  contained antibody activity only in the  upper  fractions.  An 
aliquot of  the  same  pooled  sera  was  subjected to fractionation on sephadex 
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FIG. 8.  Effect  of subsuppressive dose of 6-MP in the "primary"  and "secondary" responses 
of rabbits injected with human red blood cells. Six control rabbits and 6 animals receiving 6- 
MP were injected with 1 ml of a 50 per cent suspension of human erythrocytes at day 0 and 
day 20. Antibody activity (average of titers)  is expressed in terms of ME-sensitive  (upper 
panel) and ME-resistant  (lower panel) hemagglutinin activity. These results have been ana- 
lyzed statistically according to the t test of Student. 
G-200. The ME-sensitive antibody activity was localized to the fractions cor- 
responding to the 19S globulins and the ME-resistant antibody activity was in 
the fractions corresponding to 7S globulin. Seven days after the second antigen 
injection, control and experimental pooled sera were analyzed on sucrose gra- 
dient. The result is in Fig. 6. An aliquot of serum of 6-MP group number 5 was 272  6-MERCAPTOPURINE  EFFECT  ON  ANTIBODIES 
also subjected to chromatography on sephadex G-200 (Fig. 7). These 2 experi- 
ments confirmed that most of the ME-sensitive antibody activity of serum of 
this group was found in the heavy fractions on sucrose gradient, and in the 
fractions corresponding to 19S globulins on sephadex G-200. 
Experiments  in Rabbits.--All 12 rabbits used in this experiment had naturally 
occurring ME-sensitive heterophile antibody against human type A red cells. 
The injection of 1 ml of 50 per cent saline suspension of human type A red cells 
did not modify the fiter of this ME-sensitive antibody in either control or ex- 
perimental animals. Immunization resulted in the formation of ME-resistant 
antibody in the 6 control animals. The titer of these antibodies increased on 
day 20. A  10-day course of 6-MP treatment beginning on the day of antigen 
injection resulted in a delayed appearance of ME-resistant antibody. Three of 5 
animals formed ME-resistant antibody only after the drug was discontinued at 
a  lower titer than the control animals. In the control group a  second similar 
antigen injection at day 20 resulted in an increased titer of ME-resistant anti- 
body while the ME-sensitive antibody titer decreased. A second 10-day course 
of 6-MP beginning on the day of the second antigen injection suppressed the 
production of the ME-resistant antibody response, but not that of the ME- 
sensitive antibody response (Fig. 8). 
DISCUSSION 
The mouse and rabbit antibodies studied in these experiments were analyzed 
by 3 methods: differential susceptibility to 2-mercaptoethanol, sucrose gradient 
ultracentrifugation, and chromatography on sephadex G-200. 
On sucrose gradient ultracentrifugation ME-sensitive antibody activity was 
always found in the rapidly sedimenting fractions (19S) and ME-resistant anti- 
body activity in the more slowly sedimenting fractions (7S),  with little over- 
lapping. Chromatography on sephadex G-200 further confirmed that the ME- 
sensitive antibody activity belonged to the  -/M  class  and  the  ME-resistant 
antibody activity to the -/G class of immune globulins. The antibody activity 
of the fractions between 19S and 7S globulin were affected by ME  treatment 
only to a small extent. It is thus likely that part of the ME-sensitive antibody 
activity is not exclusively due to -/M-antibody and part  of the ME-resistant 
antibody activity not exclusively due to -/G-antibody, since 4 major classes  of 
antibodies have recently been characterized in mice (6). In this  discussion we 
will use the term ~,M-globulin (19S) for ME-sensitive antibody activity and the 
term "/G-globulin (7S) for ME-resistant antibody activity, having in mind that 
the other classes of antibodies are included in these 2 fractions. 
At a dose insufficient to completely inhibit antibody formation, 6-MP given 
during the primary response, selectively decreased the production o£ 7S anti- 
bodies and allowed the continued formation of 19S antibodies. This effect was 
seen in both mice and rabbits. Of particular interest is the observation that in Y. BOREL,  M.  FAUCONNET,  AND P. A. MIESCHER  273 
the 6-MP-treated animals in which the formation of 7S antibodies was mark- 
edly depressed, the synthesis of 19S antibodies continued long after this class of 
immunoglobulin had disappeared from the sera of control animals. These ob- 
servations are in favor of a  negative feedback effect of 7S antibodies on 19S 
antibody production. Such a mechanism has been proposed and was supported 
by the finding of Sahiar and Schwartz that specific 7S antibodies administered 
to rabbits suppressed the formation of the corresponding 19S antibodies (1). 
It is also evident from these experiments that 6-MP given during the primary 
response has effects which extend into the secondary response. Mice which had 
19S antibody in their sera as the result of 6-MP administration given with the 
first injection of antigen preferentially formed 19S antibody on restimulation. 
In control mice the secondary response is characterized by 7S antibody syn- 
thesis. It seems difficult to implicate a direct metabolic effect of the drug which 
has been discontinued for 10 days. Rather, this result indicates that the cell 
population involved in the production of 19S antibodies responds directly to the 
antigenic stimulus by an augmented production  of 7M-antibodies.  This  in- 
terpretation is supported by the work of Uhr who demonstrated that 19S anti- 
body formation could be markedly increased if a second antigen injection was 
given 8 days after the first, at a  time when circulating antibody is almost ex- 
clusively of the 19S variety (7). 
The type of antibody formed in the secondary response was dependent on the 
dose of antigen. Control mice injected with a  small dose of antigen showed a 
classical anamuestic response,  with a  rapid increase of 7S  antibody. On  the 
other hand, control mice injected with a large dose of antigen formed in addi- 
tion to 7S antibodies, a second wave of 19S antibodies. This observation con- 
firms previous  experiments  which  demonstrated  that  under  certain  experi- 
mental conditions the synthesis of 19S antibody could be a constant feature of 
the anamnestic response (8). 
Six-mercaptopurine given during the  secondary response had no effect in 
mice immunized with a large dose of antigen. Ordinarily, this dose of antigen 
results in the production of 19S antibodies in the anamuestic response, since it 
was found that 6-MP has little effect on 19S antibody production. Its lack of 
effect under these circumstances is understandable. 
In contrast to these results, 6-MP had a marked effect on mice immunized 
with the small dose of antigen. These animals produced a preferentially 19S im- 
mune response, while 7S antibody production did not rise as in the control ani- 
mals. This suppression of 7S antibody in 6-MP-treated animals may be due to 
an inhibition of the rapid proliferation of plasma cells known to occur in the 
typical 7S anamnestic response. The reappearance of 19S antibody in this situa- 
tion is most interesting. It appears possible that the feedback mechanism dis- 
cussed above does not permanently suppress  the formation of 19S  antibody, 
but that once the amount of 7S antibody decreases sufficiently, cells which were 274  6-M_ERCAPTOPURINE EFFECT ON ANTIBODIES 
formerly producing 19S antibody are again able to produce 19S antibody follow- 
ing antigenic stimulation. 
The secondary response of rabbits which have been treated with 6-MP during 
the primary and the secondary response was similar to that of mice injected 
with a  small dose of antigen and treated with 6-MP during the secondary re- 
sponse only. However, in rabbits the second course of 6-MP administration re- 
sulted in the complete suppression of 7S antibody production which took place 
in the primary response.  These animals produced exclusively 19S  antibodies 
again. Thus it appears that 6-MP treatment is another experimental condition 
allowing the formation of 19S antibody in the secondary response. 
19S and 7S antibody could be formed either by 2 different cell populations or 
by a single cell population. If 3'M- and 7G-antibodies are produced by 2 differ- 
ent populations of cells, the preferential action of 6-MP on 7S antibody forma- 
tion could be due either to a particular susceptibility of these cells to 6-MP or to 
their more rapid rate of replication, which would make them more susceptible 
to inhibition by 6-MP, an agent known to act preferentially on young and fast 
replicating cells. If the same cell population is producing first 19S and later 7S 
antibodies, the preferential action of 6-MP on the formation of the latter may 
also be explained by the difference in the rate of cell replication necessary for 
production of the early and late immune response. Thus recruitment of a large 
cell population dividing at a  slow rate would be responsible for the early 19S 
production. A few cells would then enter in an active phase of rapid prolifera- 
tion giving rise to 7S antibody producing cells.  Six-mercaptopurine would in- 
hibit this second proliferative phase of the immune response. 
SUNM&R¥ 
In  the primary response  of mice and rabbits  immunized with foreign red 
cells,  6-MP administration prolonged the formation of 19S antibody. 7S anti- 
body formation was delayed and reduced in these animals. 
Animals treated with 6-MP during primary response exhibited a preferential 
19S response when challenged in the anarnnestic response. 
Animals immunized with small doses of antigen and treated with 6-MP only 
during the secondary response,  reversed  the usual antibody pattern  and  re- 
sponded with preferential 19S antibody formation. 
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